Liquid profiling for cancer patient stratification in precision medicine: current status and challenges for successful implementation in standard care
Circulating tumor DNA (ctDNA), accurately described by the term liquid profiling (LP), enables real-time assessment of the tumor mutational profile as a minimally invasive test and has therefore rapidly gained traction, particular for the management of cancer patients. By LP, tumor-specific genetic...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
19 March 2022
|
| In: |
Diagnostics
Year: 2022, Jahrgang: 12, Heft: 3, Pages: 1-15 |
| ISSN: | 2075-4418 |
| DOI: | 10.3390/diagnostics12030748 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/diagnostics12030748 Verlag, kostenfrei, Volltext: https://www.mdpi.com/2075-4418/12/3/748 
|
| Verfasserangaben: | Verena Haselmann, Maren Hedtke and Michael Neumaier |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1886553742 | ||
| 003 | DE-627 | ||
| 005 | 20240703170603.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240423s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/diagnostics12030748 |2 doi | |
| 035 | |a (DE-627)1886553742 | ||
| 035 | |a (DE-599)KXP1886553742 | ||
| 035 | |a (OCoLC)1443669413 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 30 |2 sdnb | ||
| 100 | 1 | |a Haselmann, Verena |d 1982- |e VerfasserIn |0 (DE-588)1153803097 |0 (DE-627)1015321275 |0 (DE-576)500568154 |4 aut | |
| 245 | 1 | 0 | |a Liquid profiling for cancer patient stratification in precision medicine |b current status and challenges for successful implementation in standard care |c Verena Haselmann, Maren Hedtke and Michael Neumaier |
| 264 | 1 | |c 19 March 2022 | |
| 300 | |a 15 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.04.2024 | ||
| 520 | |a Circulating tumor DNA (ctDNA), accurately described by the term liquid profiling (LP), enables real-time assessment of the tumor mutational profile as a minimally invasive test and has therefore rapidly gained traction, particular for the management of cancer patients. By LP, tumor-specific genetic alterations can be determined as part of companion diagnostics to guide selection of appropriate targeted therapeutics. Because LP facilitates longitudinal monitoring of cancer patients, it can be used to detect acquired resistant mechanisms or as a personalized biomarker for earlier detection of disease recurrence, among other applications. However, LP is not yet integrated into routine care to the extent that might be expected. This is due to the lack of harmonization and standardization of preanalytical and analytical workflows, the lack of proper quality controls, limited evidence of its clinical utility, heterogeneous study results, the uncertainty of clinicians regarding the value and appropriate indications for LP and its interpretation, and finally, the lack of reimbursement for most LP tests. In this review, the value proposition of LP for cancer patient management and treatment optimization, the current status of implementation in standard care, and the main challenges that need to be overcome are discussed in detail. | ||
| 650 | 4 | |a cancer management | |
| 650 | 4 | |a cell-free DNA | |
| 650 | 4 | |a circulating tumor DNA | |
| 650 | 4 | |a clinical oncology | |
| 650 | 4 | |a liquid biopsy | |
| 650 | 4 | |a liquid profiling | |
| 650 | 4 | |a personalized medicine | |
| 650 | 4 | |a standard care | |
| 700 | 1 | |a Hedtke, Maren |d 1983- |e VerfasserIn |0 (DE-588)102962755X |0 (DE-627)734325169 |0 (DE-576)377492418 |4 aut | |
| 700 | 1 | |a Neumaier, Michael |d 1958- |e VerfasserIn |0 (DE-588)1028284934 |0 (DE-627)730532623 |0 (DE-576)375780580 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diagnostics |d Basel : MDPI, 2011 |g 12(2022), 3, Artikel-ID 748, Seite 1-15 |h Online-Ressource |w (DE-627)718627814 |w (DE-600)2662336-5 |w (DE-576)365413917 |x 2075-4418 |7 nnas |a Liquid profiling for cancer patient stratification in precision medicine current status and challenges for successful implementation in standard care |
| 773 | 1 | 8 | |g volume:12 |g year:2022 |g number:3 |g elocationid:748 |g pages:1-15 |g extent:15 |a Liquid profiling for cancer patient stratification in precision medicine current status and challenges for successful implementation in standard care |
| 856 | 4 | 0 | |u https://doi.org/10.3390/diagnostics12030748 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2075-4418/12/3/748 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240423 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 1028284934 |a Neumaier, Michael |m 1028284934:Neumaier, Michael |d 60000 |d 63300 |e 60000PN1028284934 |e 63300PN1028284934 |k 0/60000/ |k 1/60000/63300/ |p 3 |y j | ||
| 998 | |g 102962755X |a Hedtke, Maren |m 102962755X:Hedtke, Maren |d 60000 |e 60000PH102962755X |k 0/60000/ |p 2 | ||
| 998 | |g 1153803097 |a Haselmann, Verena |m 1153803097:Haselmann, Verena |d 60000 |e 60000PH1153803097 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1886553742 |e 4514926604 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"family":"Haselmann","display":"Haselmann, Verena","given":"Verena","role":"aut"},{"given":"Maren","role":"aut","family":"Hedtke","display":"Hedtke, Maren"},{"family":"Neumaier","display":"Neumaier, Michael","given":"Michael","role":"aut"}],"physDesc":[{"extent":"15 S."}],"name":{"displayForm":["Verena Haselmann, Maren Hedtke and Michael Neumaier"]},"recId":"1886553742","relHost":[{"part":{"extent":"15","volume":"12","text":"12(2022), 3, Artikel-ID 748, Seite 1-15","issue":"3","pages":"1-15","year":"2022"},"language":["eng"],"id":{"eki":["718627814"],"zdb":["2662336-5"],"issn":["2075-4418"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"718627814","disp":"Liquid profiling for cancer patient stratification in precision medicine current status and challenges for successful implementation in standard careDiagnostics","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 28.05.2020"],"origin":[{"dateIssuedDisp":"2011-","dateIssuedKey":"2011","publisher":"MDPI","publisherPlace":"Basel"}],"pubHistory":["1.2011 -"],"title":[{"subtitle":"open access journal","title_sort":"Diagnostics","title":"Diagnostics"}]}],"id":{"eki":["1886553742"],"doi":["10.3390/diagnostics12030748"]},"title":[{"subtitle":"current status and challenges for successful implementation in standard care","title_sort":"Liquid profiling for cancer patient stratification in precision medicine","title":"Liquid profiling for cancer patient stratification in precision medicine"}],"note":["Gesehen am 23.04.2024"],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"19 March 2022"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a HASELMANNVLIQUIDPROF1920 | ||